310 related articles for article (PubMed ID: 16192454)
1. Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness.
Matsubara S; Li G; Takeda K; Loader JE; Pine P; Masuda ES; Miyahara N; Miyahara S; Lucas JJ; Dakhama A; Gelfand EW
Am J Respir Crit Care Med; 2006 Jan; 173(1):56-63. PubMed ID: 16192454
[TBL] [Abstract][Full Text] [Related]
2. Syk activation in dendritic cells is essential for airway hyperresponsiveness and inflammation.
Matsubara S; Koya T; Takeda K; Joetham A; Miyahara N; Pine P; Masuda ES; Swasey CH; Gelfand EW
Am J Respir Cell Mol Biol; 2006 Apr; 34(4):426-33. PubMed ID: 16339999
[TBL] [Abstract][Full Text] [Related]
3. Spleen tyrosine kinase inhibition attenuates airway hyperresponsiveness and pollution-induced enhanced airway response in a chronic mouse model of asthma.
Penton PC; Wang X; Amatullah H; Cooper J; Godri K; North ML; Khanna N; Scott JA; Chow CW
J Allergy Clin Immunol; 2013 Feb; 131(2):512-20.e1-10. PubMed ID: 22981792
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of spleen tyrosine kinase attenuates allergen-mediated airway constriction.
Moy LY; Jia Y; Caniga M; Lieber G; Gil M; Fernandez X; Sirkowski E; Miller R; Alexander JP; Lee HH; Shin JD; Ellis JM; Chen H; Wilhelm A; Yu H; Vincent S; Chapman RW; Kelly N; Hickey E; Abraham WM; Northrup A; Miller T; Houshyar H; Crackower MA
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1085-92. PubMed ID: 23889698
[TBL] [Abstract][Full Text] [Related]
5. Mast cells, Fc epsilon RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant.
Taube C; Wei X; Swasey CH; Joetham A; Zarini S; Lively T; Takeda K; Loader J; Miyahara N; Kodama T; Shultz LD; Donaldson DD; Hamelmann EH; Dakhama A; Gelfand EW
J Immunol; 2004 May; 172(10):6398-406. PubMed ID: 15128831
[TBL] [Abstract][Full Text] [Related]
6. R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation.
Braselmann S; Taylor V; Zhao H; Wang S; Sylvain C; Baluom M; Qu K; Herlaar E; Lau A; Young C; Wong BR; Lovell S; Sun T; Park G; Argade A; Jurcevic S; Pine P; Singh R; Grossbard EB; Payan DG; Masuda ES
J Pharmacol Exp Ther; 2006 Dec; 319(3):998-1008. PubMed ID: 16946104
[TBL] [Abstract][Full Text] [Related]
7. Identification of the Syk kinase inhibitor R112 by a human mast cell screen.
Rossi AB; Herlaar E; Braselmann S; Huynh S; Taylor V; Frances R; Issakani SD; Argade A; Singh R; Payan DG; Masuda ES
J Allergy Clin Immunol; 2006 Sep; 118(3):749-55. PubMed ID: 16950297
[TBL] [Abstract][Full Text] [Related]
8. Syk-kinase inhibition prevents mast cell activation in nasal polyps.
Patou J; Holtappels G; Affleck K; van Cauwenberge P; Bachert C
Rhinology; 2011 Mar; 49(1):100-6. PubMed ID: 21468383
[TBL] [Abstract][Full Text] [Related]
9. A novel inhaled Syk inhibitor blocks mast cell degranulation and early asthmatic response.
Ramis I; Otal R; Carreño C; Domènech A; Eichhorn P; Orellana A; Maldonado M; De Alba J; Prats N; Fernández JC; Vidal B; Miralpeix M
Pharmacol Res; 2015 Sep; 99():116-24. PubMed ID: 26051661
[TBL] [Abstract][Full Text] [Related]
10. Effect of ageing on pulmonary inflammation, airway hyperresponsiveness and T and B cell responses in antigen-sensitized and -challenged mice.
Busse PJ; Zhang TF; Srivastava K; Schofield B; Li XM
Clin Exp Allergy; 2007 Sep; 37(9):1392-403. PubMed ID: 17845421
[TBL] [Abstract][Full Text] [Related]
11. Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness--a murine model.
Hamelmann E; Tadeda K; Oshiba A; Gelfand EW
Allergy; 1999 Apr; 54(4):297-305. PubMed ID: 10371087
[TBL] [Abstract][Full Text] [Related]
12. IgE production in CD40/CD40L cross-talk of B and mast cells and mediator release via TGase 2 in mouse allergic asthma.
Hong GU; Park BS; Park JW; Kim SY; Ro JY
Cell Signal; 2013 Jun; 25(6):1514-25. PubMed ID: 23524335
[TBL] [Abstract][Full Text] [Related]
13. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model.
Kobayashi T; Miura T; Haba T; Sato M; Serizawa I; Nagai H; Ishizaka K
J Immunol; 2000 Apr; 164(7):3855-61. PubMed ID: 10725747
[TBL] [Abstract][Full Text] [Related]
14. Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsiveness.
Hamelmann E; Cieslewicz G; Schwarze J; Ishizuka T; Joetham A; Heusser C; Gelfand EW
Am J Respir Crit Care Med; 1999 Sep; 160(3):934-41. PubMed ID: 10471622
[TBL] [Abstract][Full Text] [Related]
15. Importance of myeloid dendritic cells in persistent airway disease after repeated allergen exposure.
Koya T; Kodama T; Takeda K; Miyahara N; Yang ES; Taube C; Joetham A; Park JW; Dakhama A; Gelfand EW
Am J Respir Crit Care Med; 2006 Jan; 173(1):42-55. PubMed ID: 16192450
[TBL] [Abstract][Full Text] [Related]
16. Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice.
Nakae S; Ho LH; Yu M; Monteforte R; Iikura M; Suto H; Galli SJ
J Allergy Clin Immunol; 2007 Jul; 120(1):48-55. PubMed ID: 17482668
[TBL] [Abstract][Full Text] [Related]
17. A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent murine model of allergic asthma.
Price MM; Oskeritzian CA; Falanga YT; Harikumar KB; Allegood JC; Alvarez SE; Conrad D; Ryan JJ; Milstien S; Spiegel S
J Allergy Clin Immunol; 2013 Feb; 131(2):501-11.e1. PubMed ID: 22939756
[TBL] [Abstract][Full Text] [Related]
18. Reducing glycosphingolipid biosynthesis in airway cells partially ameliorates disease manifestations in a mouse model of asthma.
Karman J; Tedstone JL; Gumlaw NK; Zhu Y; Yew N; Siegel C; Guo S; Siwkowski A; Ruzek M; Jiang C; Cheng SH
Int Immunol; 2010 Jul; 22(7):593-603. PubMed ID: 20497953
[TBL] [Abstract][Full Text] [Related]
19. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
[TBL] [Abstract][Full Text] [Related]
20. Catalpol exerts antiallergic effects in IgE/ovalbumin-activated mast cells and a murine model of ovalbumin-induced allergic asthma.
Chiu MH; Hou TY; Fan CK; Chang JH; Lin CL; Huang SC; Lee YL
Int Immunopharmacol; 2021 Jul; 96():107782. PubMed ID: 34022666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
